Newsletters and Deep Dive digital magazine
Many people within the pharmaceutical industry are confused by the concept of data integrity?
The Data Integrity for Clinical Research Summit will showcase the most important trends and the future direction of monitoring and improving clin
The US FDA announced today that it has cleared two novel gene therapies for sickle cell disease: Vertex Pharmaceuticals' Casgevy and bluebird bio's Lyfgenia.
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio